IP Library › Granted Patent US 12,313,834
Granted Patent B2
US 12,313,834 · App. 18/302,495 · Granted May 27, 2025

Paraffin shield coating for microscope slide

Inventors: Frederick Knute Husher (Shenzhen, CN); Jee Jong Shum (Shenzhen, CN)
Assignee: SHENZHEN PRS LIMITED
G02B21/34G01N1/30G01N1/44G02B1/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,313,834
App. No.
18/302,495
Granted
May 27, 2025
Kind
B2
Abstract

A shield coating on a microscope slide, and particularly a selective application of a paraffin layer to shield biomaterials and inorganic chemical deposits from microbial attack and oxidation, and more particularly, an application of a paraffin layer on a microscope slide as an exposure shield over deposited biomaterial reactive targets. The paraffin shield layer blocks the biomaterial and chemical targets from exposure, which may lead to degradation due to oxidation and provides resistance to fungal growth, while using the existing stain processing steps to remove the paraffin from the shield and co-resident tissue section.

Claims (34)

1. A slide, comprising:

(a) a detection area for application of a sample comprising a tissue section or loose cells for staining and subsequent examination; and

(b) a control area comprising one or more targets, each of the one or more targets is reactive to a single stain,

wherein the control area further comprises imaging reference loading dots directly on the slide, and the imaging reference loading dots comprise a black reference target and a white reference target.

2. The slide as claimed in claim 1 , wherein the one or more targets are selected to uniquely bind to stains selected from a group consisting of Alcian Blue, Bielschowsky Silver Stain, Bismarck Brown, Gram Stain, Cresyl Violet, Fontana Masson, Gordan and Sweet's Silver Staining, Light Green SF or Fast Green FCF, Grocott's Methanamine Silver Method, Hall's Bilirubin Stain, Luxol Fast Blue Mucicarmine, Muller-Mowry Colloidal Iron, New Methylene Blue, Nuclear Fast Red, Oil Red O, Orange G, PAS with Diastase Digestion, Periodic Acid Schiff (PAS), Phosphotungstic acid, Picro Sirius Red, Prussian Blue Reaction, Toluidine Blue Acidified, Trichrome-Gomori's One-Step, Trichrome-Masson's, Verhoff-Van Geison, Von Kossa, Weigert's Resorcin Fuchsin, and Zeil-Neelsen.

3. The slide according to claim 1 , wherein each of the one or more targets is a blend of polyphosphoric acid and polyvinylalcohol, Sodium 4-hydroxybenzenesulfonate, Hydroquinone, Isobutanol, Phenolsulfonic acid, or p-Toluene Sulfonyl Chloride.

4. The slide according to claim 1 , comprising at least one array of two or more targets each reactive to a single stain used as part of hematoxylin-eosin staining.

5. The slide according to claim 4 , wherein the hematoxylin-eosin staining is a two or more gradient density blend of Polyphosphoric acid and Polyvinylalcohol.

6. The slide according to claim 1 , wherein the one or more targets comprises at least one array of two or more targets, each of the two or more targets is reactive to the single stain used as part of Pap smear staining.

7. The slide according to claim 6 , wherein the single stain is usable as part of Pap smear staining comprise: Orange G, Phosphotungstic acid, Light Green SF, Fast Green FCF, or Bismarck Brown.

8. The slide according to claim 6 , wherein the two or more targets are configured to bind to the single stain usable as part of Pap smear staining comprise: Sodium 4-hydroxybenzenesulfonate, Isobutanol, Phenolsulfonic acid, or p-Toluene Sulfonyl Chloride.

9. The slide according to claim 1 , further comprising an adhesive coating for binding the one or more targets to the slide, wherein the adhesive coating is covalently attached to a glass and conformal with reactive end groups selected from a group consisting of amine, amide, carboxyl, and hydroxyl.

10. The slide according to in claim 1 , wherein

the black reference target is selected from carbon dust, and

the white reference target is selected from titanium oxide, aluminum oxide, aluminum sulfate, or barium sulfate.

11. The slide according to claim 1 , further comprising a hydrophilic barrier ring for preventing a cleaned cell slurry from spreading.

12. The slide according to claim 1 , wherein the slide supports dip-n-dunk bath and capillary gap stain processing.

13. The slide according to claim 1 , further comprising a paraffin coating for the one or more targets.

14. The slide according to claim 13 , wherein the paraffin coating has a melting temperature of 50-60° C.

15. The slide according to claim 13 , wherein the paraffin coating is selected from TissuePrep by Thermo Fisher with a melting temperature of 56° C., TissuePrep 2 by Thermo Fisher with a melting temperature of 56° C., Paraplast by Leica with a melting temperature of 56° C., Paraplast plus by Leica with a melting temperature of 56° C., or Paraplast X-tra by Leica with a melting temperature of 50-54° C.

16. The slide according to claim 13 , wherein the paraffin coating is soluble in a solvent selected from xylene, Aliphatic xylene substitute, Toluene, Paint thinner, Turpentine, a 50:50 mix of Acetone & Kerosene, or a mixture thereof.

17. The slide according to claim 13 , wherein the paraffin coating protects the one or more targets from oxidation or microbial attack, and an inorganic target or inorganic deposit from reactions resulting in oxidation or airborne delivered acids and base materials; or

the paraffin coating increases a shelf life of the inorganic target or inorganic deposit on the slide.

18. A method for staining with the slide as claimed in claim 1 , comprising:

b. applying a sample to the area for application of tissue section or loose cells of the slide, wherein the sample is tissue section or loose cells;

c. applying one or more stains to the sample and the targets that could bind to the stains;

d. determining a color density of the stained tissue or cells quantitatively based on a target gradient, and assessing a staining process for tissue or cells based on

a staining result of the targets, when a paraffin coating is selectively applied to the targets on the slide and the tissue section/loose cells are also embedded in paraffin, a following step is carried out before step b:

a. removing paraffin from the paraffin embedded tissue section or loose cells and a paraffin shield coating over the targets,

wherein the removal of paraffin in step a is carried out by warming the paraffin at a temperature ranging between 65 and 75° C. for 3-10 minutes to obtain a semi-liquefied state of paraffin followed by liquefying with an organic solvent until rehydrated in a buffer solution,

wherein the organic solvent is selected from xylene, xylol, anhydrous ethanol, 95% ethanol, 70% ethanol, or 50% ethanol, each with an exposure time of nominally 3-minutes, and

wherein the targets which bind to stains for hematoxylin-eosin staining comprise Hydroquinone and a blend of polyphosphoric acid and Polyvinylalcohol; and the stains used for Pap smear staining comprise: Orange G, Phosphotungstic acid, Light Green SF, Fast Green FCF, or Bismarck Brown, the targets which bind to stains for Pap smear staining comprise: Sodium 4-hydroxybenzenesulfonate, Isobutanol, Phenolsulfonic acid, or p-Toluene Sulfonyl Chloride.

19. The method according to claim 18 , wherein the staining is hematoxylin-eosin staining, Pap smear staining or both.

20. A kit, comprising the slide according to claim 1 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2026
From: SHENZHEN PRS LIMITED
To: PROCESS RECORD SLIDE LIMITED
Reel/Frame 075963/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2023
From: SUNSTONE SCIENTIFIC LTD.
To: SHENZHEN PRS LIMITED
Reel/Frame 063521/0139 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2023
From: HUSHER, FREDERICK KNUTE; SHUM, JEE JONG
To: SUNSTONE SCIENTIFIC LIMITED
Reel/Frame 063491/0464 →
Continuity (14)
Continuation 16715715 · Dec 16, 2019
Continuation PCTCN2018091383 · Jun 15, 2018
Continuation PCTCN2018091685 · Jun 15, 2018
Continuation PCTCN2018091686 · Jun 15, 2018
Continuation PCTCN2018091687 · Jun 15, 2018
Continuation PCTCN2018091689 · Jun 15, 2018
Provisional Application 62520169 · Jun 15, 2017
Provisional Application 62520319 · Jun 15, 2017
Provisional Application 62520178 · Jun 15, 2017
Provisional Application 62520187 · Jun 15, 2017
Provisional Application 62539281 · Jul 31, 2017
Provisional Application 62520334 · Jun 15, 2017
Provisional Application 62520341 · Jun 15, 2017
Related Publication 20230280578A1 · Sep 7, 2023
References Cited (46)
US 4190314A · Goldsmith · 1980 [cited by applicant]
US 4832855A · Tanaka · 1989 [cited by applicant]
US 6855490B2 · Sompuram · 2005 [cited by examiner]
US 11300485B2 · Husher · 2022 [cited by examiner]
US 11662564B2 · Husher · 2023 [cited by examiner]
US 20030166261A1 · Sompuram et al. · 2003 [cited by applicant]
US 20050142654A1 · Matsumoto · 2005 [cited by examiner]
US 20140022631A1 · Hunnell et al. · 2014 [cited by applicant]
US 20160004900A1 · Revie · 2016 [cited by examiner]
US 20160123850A1 · Revie · 2016 [cited by examiner]
CN 1288158 · 2001 [cited by applicant]
CN 1957256 · 2007 [cited by applicant]
CN 101529247 · 2009 [cited by applicant]
CN 202002935 · 2011 [cited by applicant]
CN 102391655 · 2012 [cited by applicant]
CN 102540444 · 2012 [cited by applicant]
CN 102812392 · 2012 [cited by applicant]
CN 102939538 · 2013 [cited by applicant]
CN 103116018 · 2013 [cited by applicant]
CN 103328979 · 2013 [cited by applicant]
CN 103471892 · 2013 [cited by applicant]
CN 104086085 · 2014 [cited by applicant]
CN 204790174 · 2015 [cited by applicant]
CN 106596546 · 2017 [cited by applicant]
GB 2522231 · 2015 [cited by applicant]
GB 2524227 · 2015 [cited by applicant]
JP 200010017 · 2000 [cited by applicant]
JP 2000500321 · 2000 [cited by applicant]
WO 9712957 · 1997 [cited by applicant]
WO WO2006007726 · 2006 [cited by applicant]
WO WO2006031342 · 2006 [cited by applicant]
WO WO2009081165 · 2009 [cited by applicant]
WO WO2012078138A1 · 2012 [cited by examiner]
WO WO2012143709 · 2012 [cited by applicant]
WO WO2013008142 · 2013 [cited by applicant]
WO WO2015187158 · 2015 [cited by applicant]
WO WO2016160545 · 2016 [cited by applicant]
International search report dated Sep. 12, 2018 from corresponding application No. PCT/CN2018/091383. [cited by applicant]
Yu, X. et al., “Detachment of methacrylate-embedded sections from microscope slides can be prevented by heating on hotplate”, Journal of Histology & Histopathology, vol. 1, Dec. 31, 2014 (Dec. 31, 2014), ISSN: 2055-091X… [cited by applicant]
International search report dated Sep. 3, 2018 from corresponding application No. PCT/CN2018/091685. [cited by applicant]
International search report dated Sep. 6, 2018 from corresponding application No. PCT/CN2018/091686. [cited by applicant]
International search report dated Sep. 18, 2018 from corresponding application No. PCT/CN2018/091687. [cited by applicant]
Dupouy, D.G. et al., “Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer”, Sci. Rep., vol. 6, Feb. 9, 2016 (Feb. 9, 2016), srep20… [cited by applicant]
Taylor, C.R., “Immunohistochemistry in surgical pathology: principles and practice”, Methods Mal. Biol., vol. 1180, Dec. 31, 2014 (Dec. 31, 2014), pp. 81-109. [cited by applicant]
International search report dated Sep. 10, 2018 from corresponding application No. PCT/CN2018/091689. [cited by applicant]
Comsa, Serban et. al.; ‘The Story of MCF-7 Breast Cancer Cell Line: 40 Years of Experience in Research’, Anticancer Research, vol. 35, pp. 3147-3154, 2015. [cited by applicant]